ValueAct Capital
As of Q2 2026, ValueAct Capital reported 18 long-equity positions worth $5.63B in aggregate.
Copy-investor backtest
- Latest quarter
- +11.81%
- 1-year
- -6.13%
- 3-year
- +68.78%
- 5-year
- +54.42%
- 3-year vs S&P 500
- -4.46%
- 5-year vs S&P 500
- -19.26%
- 5-year top 5
- +37.05%
Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.
Get email alerts when ValueAct Capital files a new 13F — sign in or create a free account.
Updated 2026-06-06 from SEC 13F data.
Live quotes available for 4 of 14 rows. Rows without a quote are marked unavailable.
| 1 | VRX | VALEANT PHARMACEUTICALS INTL COM | 22.29% | - | 17,775,903 | $565.1M | No quote | No quote |
| 2 | SLE | SARA LEE CORP COM | 16.77% | - | 34,918,822 | $425.31M | No quote | No quote |
| 3 | IT | GARTNER GROUP INC NEW-CL A COM | 14.79% | - | 20,790,013 | $375.05M | $18.04 | No quote |
| 4 | BCR | C R BARD INC COM | 8.09% | - | 2,634,500 | $205.23M | No quote | No quote |
| 5 | MDZ | MDS INC COM | 6.97% | - | 23,107,700 | $176.77M | No quote | No quote |
| 6 | BFH | ALLIANCE DATA SYSTEM CORP COM | 6.58% | - | 2,583,900 | $166.89M | $64.59 | No quote |
| 7 | WSH | WILLIS GROUP HOLDINGS LTD SHS | 6.23% | - | 5,990,410 | $158.03M | No quote | No quote |
| 8 | IMA | INVERNESS MEDICAL INNOVATIONS COM | 5.59% | - | 3,413,782 | $141.71M | No quote | No quote |
| 9 | BLUD | IMMUCOR INC COM | 3.56% | - | 4,457,779 | $90.23M | No quote | No quote |
| 10 | VRSN | VERISIGN INC COM | 3.48% | - | 3,645,017 | $88.36M | $24.24 | No quote |
| 11 | SNA | SNAP ON TOOLS CORP COM | 1.97% | - | 1,180,609 | $49.89M | $42.26 | No quote |
| 12 | WCRX | WARNER CHILCOTT LIMITED COM | 1.94% | - | 1,726,848 | $49.16M | No quote | No quote |
| 13 | KAR | KAR AUCTION SERVICES INC COM | 1.23% | - | 2,258,828 | $31.15M | No quote | No quote |
| 14 | IMAPRB | INVERNESS MEDICAL INNOVATIONS PFDCONVSERB | 0.50% | - | 47,195 | $12.67M | No quote | No quote |